Home > PS Ratio > MEDICO REMEDIES

MEDICO REMEDIES
PS (Price/Sales) Ratio

The Current P/S Ratio of MEDICO REMEDIES is 2.52.

Share Price ₹52.2Dec 02,2025
Market Cap ₹433.2 Cr
Sales-TTM₹171.7 CrTTM-Standalone Results
Price/Sales2.52xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for MEDICO REMEDIES
Please provide your vote to see the results
MEDICO REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of MEDICO REMEDIES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of MEDICO REMEDIES is calculated as :

Current Market Cap [ ₹433.2 Cr] as on Dec 02,2025

(/) Sales [ ₹171.7 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 2.52x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for MEDICO REMEDIES , the investors are currently willing to pay '2.52 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of MEDICO REMEDIES !

The chart below summarizes the trend in P/S Ratio of MEDICO REMEDIES over the last five years.

Historical PS (Price/Sales) ratio chart of MEDICO REMEDIES


PS Ratio Performance Analysis for MEDICO REMEDIES

- MEDICO REMEDIES 's latest p/e ratio is 2.52x.

- MEDICO REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.32x.

- MEDICO REMEDIES 's operated at median p/e ratio of 2.82x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, MEDICO REMEDIES 's p/e ratio peaked in Mar2023 at 4.41x.

- MEDICO REMEDIES 's p/e ratio hit its five-year low in Mar2021 of 0.34x.


How does MEDICO REMEDIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
MEDICO REMEDIES 171.72.52433.2
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.85431,412.0
DIVIS LABORATORIES LTD10,029.016.99170,343.0
CIPLA LTD28,349.64.32122,511.0
TORRENT PHARMACEUTICALS LTD12,248.010.30126,191.0
DR REDDYS LABORATORIES LTD34,310.03.10106,523.0
MANKIND PHARMA LTD13,576.96.7491,485.9
ZYDUS LIFESCIENCES LTD24,493.93.8794,827.5
LUPIN LTD24,750.73.8495,164.1
AUROBINDO PHARMA LTD32,514.52.1770,654.5
ABBOTT INDIA LTD6,714.49.2562,121.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs MEDICO REMEDIES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.17x
Max industry PS 16.99x
Median industry PS 4.32x
Average industry PS 6.45x



You may also like the below Video Courses